Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response.

Rybtke M, Hultqvist LD, Givskov M, Tolker-Nielsen T.

J Mol Biol. 2015 Nov 20;427(23):3628-45. doi: 10.1016/j.jmb.2015.08.016. Epub 2015 Aug 28. Review.

PMID:
26319792
2.

The role of bacterial biofilms in chronic infections.

Bjarnsholt T.

APMIS Suppl. 2013 May;(136):1-51. doi: 10.1111/apm.12099.

PMID:
23635385
3.

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.

Bjarnsholt T, Tolker-Nielsen T, Høiby N, Givskov M.

Expert Rev Mol Med. 2010 Apr 7;12:e11. doi: 10.1017/S1462399410001420. Review.

PMID:
20370936
4.

Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.

Tolker-Nielsen T.

APMIS Suppl. 2014 Dec;(138):1-51. doi: 10.1111/apm.12335. Review.

PMID:
25399808
5.

Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.

Jakobsen TH, Bjarnsholt T, Jensen PØ, Givskov M, Høiby N.

Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Review.

PMID:
23841636
6.

Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.

Hengzhuang W, Høiby N, Ciofu O.

Methods Mol Biol. 2014;1147:239-54. doi: 10.1007/978-1-4939-0467-9_17.

PMID:
24664838
7.

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Murray TS, Egan M, Kazmierczak BI.

Curr Opin Pediatr. 2007 Feb;19(1):83-8. Review.

PMID:
17224667
8.

An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal.

Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):253-68. doi: 10.1111/j.1574-695X.2010.00690.x. Epub 2010 Apr 23. Review.

9.

The clinical impact of bacterial biofilms.

Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T.

Int J Oral Sci. 2011 Apr;3(2):55-65. doi: 10.4248/IJOS11026. Review.

10.

The Consequences of Being in an Infectious Biofilm: Microenvironmental Conditions Governing Antibiotic Tolerance.

Sønderholm M, Bjarnsholt T, Alhede M, Kolpen M, Jensen PØ, Kühl M, Kragh KN.

Int J Mol Sci. 2017 Dec 12;18(12). pii: E2688. doi: 10.3390/ijms18122688. Review.

11.

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A.

Microbes Infect. 2001 Jan;3(1):23-35. Review.

PMID:
11226851
12.

Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.

Ciofu O, Tolker-Nielsen T, Jensen PØ, Wang H, Høiby N.

Adv Drug Deliv Rev. 2015 May;85:7-23. doi: 10.1016/j.addr.2014.11.017. Epub 2014 Dec 2. Review.

PMID:
25477303
13.

Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.

Seth AK, Zhong A, Nguyen KT, Hong SJ, Leung KP, Galiano RD, Mustoe TA.

Wound Repair Regen. 2014 Nov-Dec;22(6):712-9. doi: 10.1111/wrr.12232. Epub 2015 Jan 8.

PMID:
25230854
14.

Pseudomonas aeruginosa biofilms in cystic fibrosis.

Høiby N, Ciofu O, Bjarnsholt T.

Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Review.

PMID:
21133688
15.
16.

Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.

Ciofu O, Mandsberg LF, Wang H, Høiby N.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):215-25. doi: 10.1111/j.1574-695X.2012.00983.x. Epub 2012 Jun 1. Review. Erratum in: FEMS Immunol Med Microbiol. 2012 Oct;66(1):120.

17.

Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Trøstrup H, Lerche CJ, Christophersen L, Jensen PØ, Høiby N, Moser C.

Int J Mol Sci. 2017 Jun 26;18(7). pii: E1359. doi: 10.3390/ijms18071359.

18.

[Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].

Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B.

Mikrobiyol Bul. 2009 Oct;43(4):563-73. Turkish.

PMID:
20084909
19.

The implication of Pseudomonas aeruginosa biofilms in infections.

Rybtke MT, Jensen PØ, Høiby N, Givskov M, Tolker-Nielsen T, Bjarnsholt T.

Inflamm Allergy Drug Targets. 2011 Apr;10(2):141-57. Review.

PMID:
21314623
20.

The immune system vs. Pseudomonas aeruginosa biofilms.

Jensen PØ, Givskov M, Bjarnsholt T, Moser C.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):292-305. doi: 10.1111/j.1574-695X.2010.00706.x. Epub 2010 May 28. Review.

Supplemental Content

Support Center